Your SlideShare is downloading. ×
Molecular Imaging/ Nuclear Medicine
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Introducing the official SlideShare app

Stunning, full-screen experience for iPhone and Android

Text the download link to your phone

Standard text messaging rates apply

Molecular Imaging/ Nuclear Medicine

778
views

Published on

Published in: Health & Medicine, Education

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
778
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
14
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Molecular Imaging/ Nuclear Medicine Subspecialty Content Brochure Radiological Society of North America 94th Scientific Assembly and Annual Meeting November 30–December 5, 2008 McCormick Place, Chicago RSNA2008.RSNA.org
  • 2. Subspecialty content brochures organize the components of the annual meeting by subjects that correspond to radiologic subspecialties. We hope this brochure, along with the meeting program, helps to enrich and ease your experience at RSNA 2008. RSNA Annual Meeting CME Information RSNA® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. RSNA designates this educational activity for a maximum of 87.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. indicates a course being offered as a self-assessment module (SAM). / = Syllabus/supplement available for purchase at the Education Store in RSNA Services, Lakeside Center, Level 3 or at Booth 2700, South Building, Hall A. Sunday, November 30, 2008 10:45-12:15 Scientific Paper Sessions ISP: Neuroradiology/Head and Neck (Glandular Disease) (Session SSA15) (N226) Nuclear Medicine (PET/CT Oncology) (Session SSA18) (E353C) 2:00-3:30 Refresher Courses Essentials of Molecular Imaging for Clinical Radiologists (Course RC117) (E451A) Minicourse: Clinical Trials in Imaging— Quantitative Imaging (Course RC128) (E352) Update Course in Diagnostic Radiology: Clinical PET and PET/CT Imaging—PET Basics (Course RC111) (S406B) 3:30-4:30 Multisession Course Advanced Practice in Nuclear Medicine and US (Course RA14) (S505AB) SUPPLEMENTSYLLABUS S SYLLABUS
  • 3. Monday, December 1, 2008 8:30-10:00 Refresher Courses Breast Imaging in the Era of Molecular Medicine (Course RC217) (S406B) New Thoracic Imaging Technologies: 64-Slice Multidetector CT, Postprocessing, CAD, Lung Nodule Volumetry, and MR Applications (Course RC201) (N227) Update Course in Diagnostic Radiology: Clinical PET and PET/CT Imaging—CNS PET (Course RC211) (S103CD) 10:30-12:00 Scientific Paper Sessions ISP: Molecular Imaging (Applications I) (Session SSC11) (E353A) ISP: Nuclear Medicine (PET/CT of the Neck and Chest) (Session SSC16) (E353C) 1:30-2:45 Plenary Session Eugene P. Pendergrass New Horizons Lecture and Honorary Memberships (PS50) (Arie Crown Theater) 3:00-4:00 Scientific Paper Sessions Cardiac (CT/MR Imaging in Animal Models) (Session SSE04) (S503AB) ISP: Genitourinary (Upper Tract: Gene Expression) (Session SSE10) (E352) Molecular Imaging (Imaging Agents I) (Session SSE13) (E353A) Nuclear Medicine (Brain and Central Nervous System) (Session SSE19) (E353C) 3:30-5:00 Multisession Course Fusion Imaging (Sponsored by the Associated Sciences Consortium) (Course AS24) (E350) 4:30-6:00 Special Focus Session Molecular Imaging: Making It Useful and Usable (SFF04) (E353A) Tuesday, December 2, 2008 8:30-10:00 Refresher Courses Categorical Course in Diagnostic Radiology: Cardiac—Evaluation of Ischemia with CT, MR, and Nuclear Imaging (Course RC303) (N228) GU Imaging in the Era of Molecular Medicine (Course RC317) (S505AB) Update Course in Diagnostic Radiology Physics: Imaging Technologies in Oncology—Imaging Lung Cancer (Course RC321) (E353A) Update Course in Diagnostic Radiology: Clinical PET and PET/CT Imaging—PET of the Thorax (Course RC311) (S405AB) SYLLABUS SUPPLEMENT SYLLABUS
  • 4. 10:30-12:00 Scientific Paper Sessions Cardiac (Stress Testing: CT vs SPECT/PET) (Session SSG02) (S503AB) ISP: Molecular Imaging (Applications II) (Session SSG11) (E253CD) Nuclear Medicine (PET/CT of the Gastrointestinal Tract) (Session SSG16) (E353C) 3:00-4:00 Scientific Paper Sessions Molecular Imaging (Techniques) (Session SSJ15) (E353A) Neuroradiology (Brain: Demyelination/Multiple Sclerosis) (Session SSJ18) (N226) Neuroradiology (Brain: Secondary Tumors/Metastases) (Session SSJ20) (N228) Nuclear Medicine (General) (Session SSJ21) (E353C) Breast Imaging (Multiple Modalities) (Session SSJ02) (E253CD) 4:30-6:00 Refresher Courses Gastrointestinal Imaging in the Era of Molecular Medicine (Course RC417) (S504ABC) Update Course in Diagnostic Radiology: Clinical PET and PET/CT Imaging—Abdominopelvic PET/CT and the Medicare PET Registry (Course RC411) (S103CD) Who Will Read My Molecular CT? The Impact of Migration of Physicians, Images, and Innovation (Sponsored by the RSNA Committee on International Relations and Education) (Course RC416) (S102D) Wednesday, December 3, 2008 8:30-10:00 Multisession Course Molecular Imaging: Introduction and Overview of Molecular Imaging (Course MI41) (S406B) Refresher Courses Challenges in Diagnosis and Management of the Solid Renal Mass (Course RC507) (S503AB) Interventional Radiology in the Era of Molecular Medicine (Course RC517) (N229) Minicourse: Image Optimization for Treatment Planning—Brain, Head and Neck, and Extremities (Course RC522) (S403B) Update Course in Diagnostic Radiology: Clinical PET and PET/CT Imaging—PET of Extracranial Head and Neck and Thyroid Cancer (Course RC511) (N230) 10:30-12:00 Multisession Course Molecular Imaging in Oncology (Course MI42) (S406B) SYLLABUS SYLLABUS
  • 5. Scientific Paper Sessions Cardiac (CT/MR Imaging of Plaque) (Session SSK03) (S503AB) ISP: Neuroradiology (Brain: Primary Tumors/Gliomas) (Session SSK12) (N227) ISP: Nuclear Medicine (Quantitative Imaging) (Session SSK14) (E353C) Musculoskeletal (Soft-Tissue Tumors: Quantitative and Qualitative Assessment) (Session SSK11) (S405AB) 1:30-2:45 Plenary Session Annual Oration in Radiation Oncology (PS70) (Arie Crown Theater) Multisession Course Molecular Imaging: Cardiovascular Imaging (Course MI43) (S406B) 3:00-4:00 Scientific Paper Sessions Breast Imaging (CT/Nuclear Imaging) (Session SSM01) (Arie Crown Theater) Neuroradiology (Brain: MR Spectroscopy) (Session SSM16) (N226) Physics (PET and Diffusion MR Imaging) (Session SSM22) (S403B) Molecular Imaging (Cell Tracking) (Session SSM13) (E352) Nuclear Medicine (Cardiovascular) (Session SSM19) (E353C) 3:15-4:45 Multisession Course Molecular Imaging in Neurology (Course MI44) (S406B) 4:30-6:00 Special Focus Session PET/CT: Who Should Read It? (SFN07) (E352) Thursday, December 4, 2008 8:30-10:00 Refresher Courses Imaging the Postoperative Urinary Tract (Course RC607) (E253CD) Minicourse: Innovations and Advances in Medical Imaging Technology—ACR Accreditation of SPECT and PET (Course RC623) (E352) Oncologic Imaging in the Era of Molecular Medicine (Course RC617) (E350) Update Course in Diagnostic Radiology: Clinical PET and PET/CT Imaging—Lymphoma, Melanoma, Sarcomas (Course RC611) (N228) 10:30-12:00 Scientific Paper Sessions Gastrointestinal (GI Oncology: CT/PET) (Session SSQ07) (E450A) ISP: Molecular Imaging (Imaging Agents II) (Session SSQ11) (E253CD) S SYLLABUS
  • 6. Musculoskeletal (Muscle and Nerve Disorders) (Session SSQ12) (S406B) Neuroradiology/Head and Neck (Carotid Plaque Imaging) (Session SSQ14) (N227) Nuclear Medicine (PET/CT in Lymphoma and Sarcomas) (RC) (Session SSQ16) (E353C) 4:30-6:00 Refresher Courses Neurologic Imaging in the Era of Molecular Medicine (Course RC717) (S503AB) Update Course in Diagnostic Radiology: Clinical PET and PET/CT Imaging—Clinical Cardiac PET/CT (Course RC711) (E350) Friday, December 5, 2008 8:30-10:00 Refresher Courses Cardiovascular Imaging in the Era of Molecular Medicine (Course RC817) (S103AB) Categorical Course in Diagnostic Radiology: Cardiac—New Developments in SPECT and PET of the Heart (Course RC803) (N228) Update Course in Diagnostic Radiology: Clinical PET and PET/CT Imaging—Emerging PET Applications (Course RC811) (N227) 10:30-12:00 Scientific Paper Sessions Musculoskeletal (Bone Tumors) (Session SST09) (S405AB) Neuroradiology (Brain: Vascular Noninvasive Imaging—New Techniques) (Session SST12) (N228) Nuclear Medicine (Endocrine and Neuroendocrine) (Session SST13) (E353C) Education Exhibits CME is available when author is present for discussion during the lunch period. Days listed in parantheses. Space No. Exhibit Title LL-CH4787 Metabolic and Morphologic Mapping of Primary Pulmonary Neoplasms: Imaging Review with Cytopathologic Correlation LL-CH4800 Usefulness of PET/CT in Detection of Malignancy Arising from Chronic Inflammation LL-GI3156-B The Acute GI Bleeder (Sunday) LL-GI3211 What the Radiologist Should Know about the Spleen LL-GI4983 Imaging in the Work-up of Colorectal Metastasis to the Liver: The Use of CT, MR, and PET Imaging Guiding the Surgical and Interventional Management of Metastasis LL-GI5032 Splenic Ectopia and Variants: A Multimodality Approach SUPPLEMENT SYLLABUS SYLLABUS
  • 7. LL-GI5055 Pictorial Review of Pancreatic Metastasis from Renal Cell Carcinoma LL-GI5056 Advances in Imaging of Pancreatic Neuroendocrine Tumours (PNETs) LL-GI5090 Colon Cancer from Presentation to Treatment: The Radiology of Diagnosis, Staging, Treatment, and Surveillance LL-GI5092 Gastroenterological and Radiological Approach of Obscure Gastrointestinal Bleeding (OGIB): How, Why, When? LL-MI1001 High-Resolution in Vivo Stem Cell Tracking in the Myocardium of Small Laboratory Animals: Feasibility and Acquisition Strategies on Clinical Magnetic Resonance Imaging (MRI) Scanning Platforms LL-MI1002 Dynamic Contrast-enhanced MR Imaging: A Useful Tool for Cancer Diagnosis and Monitoring of Angiogenic Inhibitor Therapy LL-MI2500-H04 Proteomics and Genomics: Molecular Medicine Tools for Radiologists (Tuesday) LL-MI2501 MRI as a Versatile Tool in Molecular Imaging LL-MI2502-L04 Test Your Skills for Nodal Characterization in Lymphotropic Nanoparticle-enhanced MRI! (Wednesday) LL-MI2503 Imaging of Biodegradable Tissue-engineered Materials for Tissue Regeneration LL-MI2504 An Easy Guide to Label Cells in Vitro with Gadolinium LL-MI2505 Imaging Vascular-Metabolic Relationships in Tumors LL-MK3238 DXA T-score: Fundamentals of DXA Scanning, Interpretation, and Reporting—Yes, I Said Interpretation! LL-MK3256 Ewing Sarcoma: Utility of FDG Positron Emission Tomography in Staging, Restaging, and Assessment of Therapy Response LL-MK5223 FDG-PET in Differentiating Benign from Malignant Compression Fractures LL-MK5232-B12 Current Concepts in the Evaluation of Multiple Myeloma with MRI and PET/CT (Sunday) LL-MS3042 Revisit Lymphedema: Correlation with Lymphoscintigraphy and MDCT LL-MS4583 Comparison between FDG-PET/CT and Diffusion- weighted MR Imaging Findings: Similar and Different Points for Effective Understanding LL-NM1030 How to Clearly Visualize Lymph Node Metastases in the Pelvic Cavity on FDG PET Images LL-NM1031 Whole Body 18F-FDG PET/CT Images of HIV/AIDS- related Disease LL-NM1032 Evaluation of Oral Cavity Carcinomas by 18FDG PET/CT: Normal Variations, Diagnostic Pathologic Patterns, with Illustrative Case Examples LL-NM1033 F18-FDG PET/CT in Pediatric Malignancies LL-NM1034 Role of PET-CT in the Evaluation of Patients with Head and Neck Neoplasms: Neuro PET/CT
  • 8. LL-NM1035-R Thoracic PET-CT from A to Z: Part I—Patient Preparation, Acquisition Techniques, Basic Anatomical Features, Normal 18FDG-uptake and Its Variants, and Nonmalignant 18FDG-uptake Lesions (Thursday) LL-NM1036 Evaluation of Complex Nodal Basin Drainage with SPECT/CT Lymphoscintigraphy LL-NM1037 CT Component of 18FDG PET/CT: Technical Considerations, Protocols, and Diagnostic Value LL-NM1038 Hyperthyroidism: Common Etiologies and Treatment with Radioactive Iodine LL-NM2506 Parathyroid Imaging Pearls and Pitfalls LL-NM2507 Octreotide Imaging of Neuroendocrine Tumors: Synergy of a Peptide Radiotracer with CT and MR Anatomic Correlation LL-NM2508 Clinical Value of 3D Fused Image of Myocardial Perfusion SPECT and CT Coronary Angiography LL-NM2509-R06 When Is a Bone Scan Not a Bone Scan? Examples of Nonosseous Pathology on Bone Scintigraphy (Thursday) LL-NM2510 Congenital Neonatal Hypothyroidism: On Thyroxine for Life? Find Out Sooner Rather than Later with the Thyroid Isotope Scan LL-NM2511 DAT SPECT: Know Your Dopamine Transport Receptor Imaging LL-NM2512 FDG PET and PET/CT Findings in Infectious and Inflammatory Diseases LL-NM2513-D09 SPECT/CT in Malignant and Benign Skeletal Disease: Localization and Characterization (Monday) LL-NM2514 Helping the Endocrine Surgeon: Multimodality Imaging in Hyperparathyroidism LL-NM2515 Multimodality Imaging in Suspected Thyroid Cancer Recurrence LL-NM2516 Slow Drainage on Isotope Renography in a Child: Obstructed or Not Obstructed? The Perennial Urological Question Explored LL-NM2517 Diagnosing Complications after Kidney Transplant: What Is the True Value of Renal Scintigraphy? LL-NM2518 Applications of SPECT/CT in Hepatic/Hepatobiliary Imaging LL-NM2519 Musculoskeletal Non-Oncologic Imaging with PET/CT LL-NM2520 Preoperative Estimation of Superficial Esophageal Cancer in FDG-PET: Correlation with Histopathology LL-NM2521 Clinical Application of C-11 Methionine PET for the Evaluation of Brain Tumors LL-NM2522 Radiologic, Metabolic, and Pathologic Pitfalls in the Interpretation of PET/CT Imaging LL-NM2523-D08 18F FDG PET/CT Evaluation of Osseous Malignancies and Soft Tissue Sarcomas: A Pictorial Review (Monday) LL-NM2524 Advantages of Whole-body MRI and FDG-PET Fused Images over FDG-PET/CT for Evaluation of Patients with Cancer: A Pictorial Essay
  • 9. LL-NM2525 Utility of F18 FDG PET/CT in Evaluating Radiological Response to the New Targeted Molecular Therapies for Cancer LL-NM2526 Integrated PET/CT in Management of Breast Cancer and in Cancers of the Female Reproductive Tract LL-NM2527 PET/CT in Breast Cancer LL-NM2528-B09 Thoracic PET/CT from A to Z: Part II—Malignant Disease of the Thorax (Sunday) LL-NM2529-H08 Abdominal PET/CT from A to Z: Part II—A Practical Approach to Abdominal Malignancies (Tuesday) LL-NM2530-R07 Abdominal PET/CT from A to Z: Part I—Patient Preparation, Acquisition Techniques, Anatomical Landmarks, Normal Uptake, and Its Variants (Thursday) LL-NM2531 PET/CT Evaluation of Multiple Synchronous Primary and Recurrent Malignancies LL-NM2532 SPECT/CT and PET/CT Evaluation of Patients with Musculoskeletal Pathology LL-NM2533 Metastasis or Not? Hot-uptake Lesions of FDG- PET Scan in Patients with Breast Cancer LL-NM2534 FDG-Uptake Associated with Benign Lesions on PET/CT: A Pictorial Review LL-NM2535 Malignant Lymphoma Post Therapy: Usefulness and Pitfalls Using FDG-PET/CT Compared to CT, MRI, and Ga Scintigraphy LL-NM2536 Making SUVs Work for You: Proper Use of SUVs in PET/CT Image Interpretation and Reporting LL-NM2537 Colorectal Cancer: Patterns of Locoregional Recurrence and Distant Metastases as Demonstrated by FDG PET/CT LL-NM2538 Metastatic Spread Patterns of Thyroid Carcinoma: A PET/CT-based Pictorial Review LL-NM2539-L08 Common False Positive Findings on FDG PET/CT: An Atlas of Artifacts, Normal Variants, and Incidentals (Wednesday) LL-NM2540 Evaluation of Emergent Acute Nononcologic Findings on FDG PET-CT LL-NM2541 PET/CT Enterography in Crohn Disease LL-NM2542 FDG-PET/CT Findings of Extranodal Involvement in Patients with Non-Hodgkin Lymphoma (NHL) and Hodgkin’s Disease (HD) LL-NM2543-H09 18F FDG-PET/CT of Atherosclerotic Disease: Imaging the Vulnerable Plaque—A Literature and Pictorial Review (Tuesday) LL-NM2544 18F-Fluoride Skeletal PET/CT: A Comprehensive Scintigraphic Tool to Evaluate Skeletal Pathology LL-NM2545-B08 CT Protocol Optimization for PET/CT in Oncology (Sunday) LL-RO4500-D11 Multidisciplinary Management of Bone Metastases with Special Commentary on the Role of Single Fraction Radiation (Monday) LL-RO4503-L11 The Immunopathogenesis of Radiation-induced Fibrosis (Wednesday)
  • 10. LL-UR1232 C-11 Choline Positron Emission Tomography of Prostate Cancer: A Pictorial Guide Scientific Posters CME is available when author is present for discussion during the lunch period. Days listed in parantheses. Space No. Exhibit Title LL-MI2000-B01 Functional Detection of Glucose Oxidase Activity by Electron Transfer to Quantum Dots (Sunday) LL-MI2001-B02 Optical Imaging of Cellular Immunotherapy against Prostate Cancer (Sunday) LL-MI2002-B03 Assessment of Near-infrared Fluorescence Imaging in Collagen-induced Arthritis Using Cy5.5 Conjugated with Hydrophobically Modified Glycol Chitosan Nanoparticle: Correlation between 18F- FDG PET (Sunday) LL-MI2003-B04 Optical/CT Colon Cancer Detection Probes (Sunday) LL-MI2004-D01 Molecular MR Imaging of Opioid Receptors in Brain Using a Novel Spin-labeled Peptide Strategy (Monday) LL-MI2005-D02 Early Detection of Bone Marrow Metastasis Using Thermally Cross-linked Superparamagnetic Iron Oxide Nanoparticles: Enhanced MR Imaging in Murine Breast Cancer Model (Monday) LL-MI2006-D03 Feasibility of Cellular Magnetic Particle Imaging (Monday) LL-MI2007-H01 Bioluminescence Imaging as Novel Approaches for Studying Mechanism of Estrogen Receptor Action (Tuesday) LL-MI2008-H02 Treatment Effects of a Pan-Aurora Kinase Inhibitor Against T315I Mutant Form of BCR-ABL: Evaluation with Micro-PET and -CT (Tuesday) LL-MI2009-H03 Changes in Muscle Innervation Demonstrated on 18F-FBT PET (Tuesday) LL-MI2010-L01 The Correlation between Liver Function and Equivalent Cross-relaxation Rate (Wednesday) LL-MI2011-L02 Superparamagnetic Iron Oxide Labeling of Chondrocytes for in Vivo Tracking (Wednesday) LL-MI2012-L03 Manganese-enhanced Functional MRI of Isolated Human Pancreatic Islets (Wednesday) LL-MI2013-R01 Evaluation of Molecular Imaging to Determine Responsiveness of Lung Cancer to EGFR Kinase Inhibition (Thursday) LL-MI2014-R02 Serial Imaging of Vessel Injury with Gadofluorine in the Aorta of New Zealand White Rabbits by High-Resolution MR Microscopy (Thursday) LL-MI2015-R03 Evaluation of the Folate-Receptor Targeted Contrast Agent P1133 for Magnetic Resonance Imaging of Breast Cancer (Thursday) LL-NM2016-B01 Thallium 201 Brain SPECT Is More Sensitive than FDG-PET for the Detection of Recurrence in Patients with Brain Tumors (Sunday) LL-NM2017-B02 The Role of Early Postoperative Three-phase Bone Scan in the Evaluation of Mandibular Reconstruction with a Free Fibular Flap in Patients with Head and Neck Cancer (Sunday)
  • 11. LL-NM2018-B03 Role of 18 F FDG-PET/CT in Lymphoma Patients with Bone Metastasis (Sunday) LL-NM2019-B04 Influence of Bowel Preparation before 18F-FDG- PET/CT on Physiologic FDG Activity in the Intestine (Sunday) LL-NM2020-B05 The Relative Utility of FDG-PET and Octreoscan SPECT in the Detection of Neuroendocrine Tumors (NET): A Retrospective Analysis (Sunday) LL-NM2021-B06 Detection of Gastric Cancer Using F-18 FLT PET: Comparison with F-18 FDG PET (Sunday) LL-NM2022-B07 Advantages of FDG PET/MR over PET/CT in Evaluating Pancreatic Cancer (Sunday) LL-NM2023-D01 Metallic Artifacts of CT Caused by Dental Metal Prostheses on the Oral Cavity: A PET/CT Phantom Study (Monday) LL-NM2024-D03 Breast Cancer: Diagnosis of Recurrent and/or Metastatic Disease Using 18F FDG-PET/CT (Monday) LL-NM2025-D04 Photon Deficiency of the Vertebrae on F-18 FDG PET Imaging Study (Monday) LL-NM2026-D05 Clinical Value of FDG-PET for Musculoskeletal Malignancies (Monday) LL-NM2027-D06 18F-FDG Uptake in Operable Non-small Cell Lung Carcinoma in Comparison with Pathological Vessel Invasion and Nodal Metastasis (Monday) LL-NM2028-D07 18-FDG PET/CT in the Detection of Tumor Thrombosis (Monday) LL-NM2029-D08 Feasibility of F-18-FDG PET/CT in Detection of Spinal Cord Disorders and Malignant Neoplasms (Monday) LL-NM2030-H01 Gastric and Esophageal FDG-avidity on PET Relates to Hiatus Hernia (Tuesday) LL-NM2031-H02 Comparison of Gated Myocardial Perfusion SPECT with Contrast-enhanced MRI for Detection of Myocardial Damage in Dysfunctional Myocardium (Tuesday) LL-NM2032-H03 Differential Diagnosis of Mass-forming Pancreatic Diseases with [F-18] Alpha-methyl Tyrosine PET (Tuesday) LL-NM2033-H04 Comparison of FDG PET Scan with 99mTc-MDP Bone Scan for the Detection of Bone Metastasis in Patients with Breast Cancer (Tuesday) LL-NM2034-H05 Role of F-18 FDG PET/CT in Staging of Head and Neck Cancer (Tuesday) LL-NM2035-H06 FDG PET-CT Characterization of Adrenal Lesions (AL) (Tuesday) LL-NM2036-H07 Clinicopathological Study with F-18-FDG PET for Assessing Metabolic Activity of Arthritis in Patients with Rheumatoid Arthritis (Tuesday) LL-NM2037-L01 Evaluation of a Degree of Malignancy, Prediction of Axillary Lymph Node Metastasis with Accumulation on FDG- PET/CT in Preoperative Breast Cancer (Wednesday) LL-NM2038-L02 Diagnosis of Ischemic Heart Disease with Myocardial Perfusion Scintigraphy in High Risk Asymptomatic Patients (Wednesday)
  • 12. LL-NM2039-L03 Regional Cerebral Blood Flow SPECT in Patients with Amnesic Mild Cognitive Impairment and Early Alzheimer’s Disease (Wednesday) LL-NM2040-L04 The Risk Group Assessment of Gastrointestinal Stromal Tumor by FDG PET (Wednesday) LL-NM2041-L06 Clinical Applications of 99mTc-Tetrofosmin SPECT in Brain Tumors (Wednesday) LL-NM2042-L07 The Added Value of PET/CT Scan in the Evaluation of Adrenal Lesions Compared to PET Alone and Unenhanced CT (Wednesday) LL-NM2043-L08 The Role of C-11 Methionine PET for Non-invasive Grading Between Oligodendroglial Tumor and Other Brain Tumors (Wednesday) LL-NM2044-R01 Can a Perfusion-only Lung Scan Provide Accurate Determination of Pulmonary Embolus Probability When Lower Radiation Dose is Essential or Ventilation Study Cannot Be Performed? (Thursday) LL-NM2045-R02 Low Dose Gallium Scintigraphy in the Diagnosis of Sarcoidosis (Thursday) LL-NM2046-R04 Correlation of PET and MRI Imaging Data with Psychiatric Evaluation of Patients with and without Obsessive Compulsive Disorder (OCD) (Thursday) LL-NM2047-R05 Bronchial Anthracofibrosis: 18F-FDG PET/CT Findings in 10 Cases (Thursday) LL-NM2048-R06 Precise PET/CT Diganosis for Malignant Pleural Mesothelioma (Thursday)